. FRET-based control experiments measuring PKA activity. (A) The basal PKA activities (Y/C) of CHO-α4WT, CHO, and CHO-B2 cells were plotted against YFP intensity index, which represents the transfection efficiency of AKAR4-Kras. Linear regression was performed to evaluate the correlation of PKA activity and YFP intensity index in confined and unconfined cells. P-value and R-squared values are indicated. (B) CHO-α4WT cells either expressing AKAR4-Kras or TA-Kras were plated on unconfined spaces and induced to migrate into 3 µm channels to experience confinement. Bar graph represents the percentage increase of PKA activity 30 min after addition of forskolin (50 µM) and IBMX (100 µM). Figure S5 . Effects of modulation of PKA activity on focal adhesion, stress fiber densities and stiffness. CHO-α4WT or CHO cells were plated on fibronectin-coated coverslips in presence of vehicle control, the PKA inhibitor RpcAMPs, or the PKA inducer forskolin. (A and B) Cells stained with phalloidin (green) and with an antibody specific for paxillin (red) were imaged by confocal microcopy. To evaluate myosin II activity, focal adhesion densities were quantified as the ratio of the total area of focal adhesions to the cell spreading area. Stress fiber densities were also quantified as the ratio of the total area of stress fibers to the cell spreading area (C and D). Time-lapse FRET ratiometric images of a CHO-α4WT cell expressing Yellow Cameleon 3.6 during its transition from an unconfined 2D area into a 3 µm-wide microchannel. Images were analyzed by FRETincorporated time-lapse videomicroscopy (Nikon). Frames were taken every 15 min. Related to Figure 3. 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Cell culture, pharmacological inhibitors, plasmids and transfection: CHO-α4WT and CHO-α4S988A cell lines were generated by stably transfecting CHO cells with pQN4G and pQN4S988AG plasmids, respectively, in which wild-type or mutant α4 integrin cDNA was tagged with GFP by inserting into a PGBI25-fN1 GFP vector (Dikeman et al., 2008; Pinco et al., 2002) . The CHO-α4WT cells were maintained in Ham's F12 (Cellgro). CHO and CHO-B2 cells (Schreiner et al., 1989) were maintained in DMEM (high glucose, Life technology) and minimal essential medium (Invitrogen), respectively. Media were supplemented with 10% fetal bovine serum (FBS, Gibco) and 1 µg/ml penicillin/streptomycin. The following pharmacological agents were used in intervention studies: 50 µM forskolin (Santa Cruz), 50 µM Rp-cAMPs (Santa Cruz), 10 µM GsMTx4 (Abcam), 100 µM 3-isobutyl-1-methylxanthine (IBMX) (Santa Cruz), 100 µM 8 methoxy methyl IBMX (8MM-IBMX) (Axxora), rolipram (Cayman Chemical), 1 µM milrinone (Enzo Life Sciences), and 1 µM latrunculin (Santa Cruz). In transient knockdown experiments, PDE1 siRNA (Santa Cruz for CHO cells and OriGene for A375-SM cells) and Piezo1 siRNA (Santa Cruz for CHO cells and Life technology for A375-SM cells) were used. Transient transfection was performed using Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol
Microfluidic-based microchannel assay: A PDMS-based microchannel device was fabricated as previously described Hung et al., 2013; Tong et al., 2012) . The device was then attached to a glass slide (FisherFinest), followed by pre-coating with 20 µg/ml fibronectin at 37 °C for 1 h. The microchannel device was washed with PBS (1X) containing Ca 2+ /Mg 2+ for 1 min before seeding cells. A total of 1x10 5 cells in a 50 µl volume were added to the cell inlet port. Chemotactic-driven cell migration was recorded via time-lapse microscopy (inverted Eclipse Ti microscope, Nikon) using software controlled stage automation (Nikon). To calculate migration velocity, the cell center was identified as the midpoint between poles of the cell body, and was tracked for changes in X, Y position at 20-min intervals over a 10 h period.
Fabrication of 1D Protein Micropatterns:
Standard lithography was used to create a silicon wafer with an array of features of prescribed dimensions (50 µm wide, 5 µm tall, and 20 mm long), separated from each other by 8µm. Replica molding was used to create a PDMS stamp bearing an array of 8 µm-wide lines. Stamps were functionalized with 100µg/mL fibronectin (Sigma-Aldrich) in Dulbecco's Phosphate Buffered Saline (PBS) (Life Technologies). After 1 h at room temperature (RT), this solution was removed and the stamps were again dried under an air stream. Stamps were then inverted onto tissue culture dishes (Falcon) under steady pressure. After 30 min, the stamps were removed and the dish was backfilled with 2.5% Bovine Serum Albumin (BSA; Sigma-Aldrich) in PBS to prevent cell adhesion outside of the fibronectinpatterned areas. After 1 h the BSA solution was removed and the stamps were rinsed 3X with PBS. 2D areas were created using a flat PDMS stamp.
RNA extraction and quantitative RT-PCR:
Total RNA was extracted from cells using the NucleoSpin RNA Kit (Macherey-Nagel) and cDNA was synthesized using SuperScript III (Invitrogen). Quantitative RT-qPCR was performed with Power SYBR Green Master Mix (Applied Biosystems) using GAPDH as endogenous normalization control. Primer sequences were: 
